Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China

Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China

This protocol was developed to conduct population-wide surveillance of the bivalent HPV-16/18-AS04-adjuvanted human papillomavirus (HPV) vaccine in terms of uptake and safety outcomes including potential immune-mediated diseases (pIMDs) and pregnancy-related outcomes in China. The study will use ele...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Junting Yang, Sarah Welby, Zhike Liu, Siwei Deng, Guangxu Liu, Ruogu Meng, Yu Yang, Yixin Sun, Yunkun He, Ning Jiang, Zhenhua Wu, Keruo Liu, Dominique Rosillon, Catherine Cohet, Siyan Zhan
Format: Artikel
Sprache:English
Veröffentlicht: Taylor & Francis Group 2024-12-01
Schriftenreihe:Human Vaccines & Immunotherapeutics
Schlagworte:
HPV-16/18-AS04
human papillomavirus vaccine
safety
potential immune-mediated diseases
pregnancy outcomes
Online Zugang:https://www.tandfonline.com/doi/10.1080/21645515.2024.2378535

Online

https://www.tandfonline.com/doi/10.1080/21645515.2024.2378535

Ähnliche Einträge